Journal Home
Search for

Volume 32, Issue 4, Pages 224-228 (October 2009)


View previous. 5 of 11 View next.

Phyllodes Tumour of the Breast: Clinicopathological Analysis of Recurrent vs. Non-recurrent Cases

P.R.K. Bhargav, Anjali MishraCorresponding Author Informationemail address, G. Agarwal, A. Agarwal, A.K. Verma, Saroj Kanta Mishra

Accepted 15 September 2009.

Background

The aim of this study was to present our experience of dealing with patients with phyllodes tumours (PT) and to correlate the risk of local recurrence with different clinicopathological factors.

Materials and Methods

This was a retrospective study of 25 women with PT, who were managed at our centre between 1991 and 2005. All the available clinical, operative and histological details were retrieved. The median follow-up period was 4 years (range, 1–9 years). Various clinicopathological features were compared between patients who suffered from recurrent tumours to those not experiencing any recurrence.

Results

The mean age of the patients was 45 ± 7 years and the mean duration of symptoms was 30 ± 10 months. The mean tumour diameter was 10.5 ± 5 cm. Preoperative diagnosis with fine needle aspiration cytology could be made in 72% of cases. Overall, 39 surgical procedures were performed (14 of which were performed for recurrences). The histology report was benign, borderline and malignant PT in 28%, 20% and 52% of cases respectively. Recurrent tumours were observed in 36% of patients and 16% experienced more than one recurrence. Two patients with malignant PT developed metastases in the follow-up period, and one of them died. Except for the extent of primary surgery, there were no significant differences in other clinicopathological factors between the recurrent and non-recurrent groups. Patients who had wide local excision (WLE) and procedures of greater magnitudes as primary procedures did not experience recurrence (p = 0.008). However, when WLE was performed for recurrent tumours, 50% of patients suffered from recurrence.

Conclusion

WLE seems to be the initial procedure of choice for all PTs, and mastectomy for recurrent tumours. Further studies are needed to define the role of adjuvant therapies.

No full text is available. To read the body of this article, please view the PDF online.

Article Outline

Abstract

References

Copyright

References 

return to Article Outline

1. 1 Reinfuss M , Mitus J , Duda K , et al.   The treatment and prognosis of patients with phyloides tumour of the breast: an analysis of 170 cases . Cancer . 1996;77:910–916 .

2. 2 Bennett IC , Khan A , De Freitas R , et al.   Phyllodes tumours: a clinicopathological review of 30 cases . Aust N Z J Surg . 1992;62:628–633 . MEDLINE

3. 3 Hadju SL , Espinosa MH , Robbins G . Recurrent cystosarcoma phyllodes: a clinicopathologic study of 32 cases . Cancer . 1976;38:1402–1406 .

4. 4 Azzopardi JG . Sarcoma of the breast . In:  Bennington J editors. Problems in Breast Pathology . Philadelphia: WB Saunders Co.; 1979;p. 355–359 .

5. 5 Salvadori B , Cusumano F , Del Bo R , et al.   Surgical treatment of phyllodes tumours of the breast . Cancer . 1989;63:2532–2536 .

6. 6 Contarini O , Urdaneta LF , Hagan W , et al.   Cystosarcoma phyllodes of the breast: a new therapeutic proposal . Am Surg . 1982;48:157–166 . MEDLINE

7. 7 Gabriele R , Borghese M , Corigliano N , et al.   Phyllodes tumour of the breast. Personal contribution of 21 cases . G Chir . 2000;21:453–456 . MEDLINE

8. 8 Stebbing JF , Nash AG . Diagnosis and management of phyllodes tumour of the breast: experience of 33 cases at a specialist centre . Ann R Coll Surg Engl . 1995;77:181–184 . MEDLINE

9. 9 Iau PT , Lim TC , Pnq DJ , et al.   Phyllodes tumour: an update of 40 cases . Ann Acad Med Singapore . 1998;27:200–203 . MEDLINE

10. 10 Jacklin RK , Ridgway PF , Ziprin P , et al.   Optimising preoperative diagnosis in phyllodes tumour of the breast . J Clin Pathol . 2006;59:454–459 . MEDLINE | CrossRef

11. 11 Rowell MD , Perry RR , Hsiu JG , et al.   Phyllodes tumours . Am J Surg . 1993;165:376–379 . MEDLINE | CrossRef

12. 12 Kok KY , Telesinghe PU , Yapp SK . Treatment and outcome of cystosarcoma phyllodes in Brunei: a 13-year experience . J R Coll Surg Edinb . 2001;46:198–201 . MEDLINE

13. 13 Palshof T , Blickert-Taft M , Daehnfelt L . Estradiol binding protein in cystosarcoma phyllodes of the breast . Eur J Cancer . 1980;16:591–593 .

14. 14 Burton GV , Hart LL , Leigh GS , et al.   Cystosarcoma phyllodes: effective therapy with cisplatin and etoposide chemotherapy . Cancer . 1989;63:2088–2092 .

15. 15 Hawkins RE , Schofield JB , Wiltshaw E , et al.   Ifosfamide is an active drug for chemotherapy of metastatic cystosarcoma phyllodes . Cancer . 1992;69:2271–2275 .

Department of Endocrine Surgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

Corresponding Author InformationAddress correspondence and reprint requests to Assistant Professor Anjali Mishra, Department of Endocrine Surgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Road, Lucknow 226 014, India

PII: S1015-9584(09)60398-5

doi:10.1016/S1015-9584(09)60398-5


View previous. 5 of 11 View next.